The study says the two inactivated vaccines developed by Sinopharm prevented symptomatic infections by 72.8% & 78.1%, largely in-line with what the drugmaker previously announced.
Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.
A notice issued to foreign journalists in Beijing Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group.
CanSino has applied for regulatory approval in Pakistan and will be give the country preferential access to the single-shot vaccine. Pakistan is yet to start its vaccination drive.
The vaccine has already been administered to hundreds of thousands of people under emergency authorization in China, but it’s yet to receive public use approval from any drug regulators.
French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS